Abstract
Objective: To validate a revised version of the KIMRISS method for quantification of BML and synovitis-effusion in the knee by comparison with an established method, MOAKS. Methods: Novel calibration tools were developed for both methods. We compared reliability for status and change scores of BML and synovitis-effusion on baseline and one-year MRI scans. Results: Significant increase in both BML and synovitis-effusion was evident using KIMRISS but only for synovitis-effusion using MOAKS. Pre-specified targets for acceptable reliability (≥0.80 and ≥0.70 for status and change scores, respectively) were achieved more frequently for KIMRISS for both BML and synovitis. Conclusion: Per OFISA criteria, KIMRISS should progress to assessment of discrimination.
Original language | English |
---|---|
Journal | Seminars in Arthritis and Rheumatism |
Volume | 51 |
Issue number | 4 |
Pages (from-to) | 925-928 |
ISSN | 0049-0172 |
DOIs | |
Publication status | Published - 2021 |
Bibliographical note
Publisher Copyright:© 2021 Elsevier Inc.
Keywords
- Bone marrow lesions
- Knee inflammation MRI scoring system (KIMRISS)
- MRI
- OMERACT
- Osteoarthritis